Publication:
Evaluation of diagnostic performance of bd max ebp assay in patients with diarrheal illness

dc.contributor.authorÖzyurt, Özlem Koyuncu
dc.contributor.authorSaglik, İmran
dc.contributor.authorÖzhak, Betül
dc.contributor.authorMutlu, Derya
dc.contributor.authorLevent, Belkıs
dc.contributor.authorDönmez, Levent
dc.contributor.authorOngut, Gözde
dc.contributor.authorÇolak, Dilek
dc.contributor.authorOğunç, Dilara
dc.contributor.buuauthorSAĞLIK, İMRAN
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Mikrobiyoloji Anabilim Dalı.
dc.contributor.orcid0000-0003-0864-4989
dc.contributor.researcheridA-4970-2019
dc.date.accessioned2024-11-15T11:57:04Z
dc.date.available2024-11-15T11:57:04Z
dc.date.issued2022-12-01
dc.description.abstractObjective: Detection of the etiological agents in patients with acute diarrhea is challenging due to a wide variety of pathogens. The aim of this study is to evaluate the diagnostic performance of BD Max Enteric Bacterial Pathogens (EBP) PCR assay in patients with diarrheal illness.Methods: Between 1 January 2014 and 31 May 2015, stool samples from pediatric or adult patients with diarrhea submitted for routine analysis of bacterial stool pathogens were included in the study. We compared the BD Max EBP PCR assay to culture for the detection of Salmonella spp., Shigella spp., Campylobacter jejuni, and Campylobacter coli and an EIA for Shiga toxins 1 and 2. Discordant results were adjudicated by either antigen detection methods or Film array GI Panel.Results: When coinfections were excluded, the positive percent agreement values for the BD Max EBP assay (PPA) was 100% and negative percent agreement (NPA) was between 98.0%-99.7%, when compared with culture and EIA. After discrepant analysis, the PPA values for the BD Max EBP assay was 100% and NPA was between 99.5%-100%.Conclusion: The BD Max EBP assay showed a high correlation rate with conventional and molecular methods for the detection of stool pathogens.
dc.identifier.doi10.58600/eurjther-28-4-0098
dc.identifier.endpage300
dc.identifier.issn2564-7784
dc.identifier.issue4
dc.identifier.startpage297
dc.identifier.urihttps://doi.org/10.58600/eurjther-28-4-0098
dc.identifier.urihttps://eurjther.com/index.php/home/article/view/36
dc.identifier.urihttps://hdl.handle.net/11452/47933
dc.identifier.volume28
dc.identifier.wos000968675000008
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherPera Yayıncılık Hizmetleri
dc.relation.journalEuropean Journal of Therapeutics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectEnteric bacterial panel
dc.subjectPractice guidelines
dc.subjectManagement
dc.subjectCulture
dc.subjectOsteoarthritis
dc.subjectKnee joint
dc.subjectTalocrural joint
dc.subjectTransverse tarsal joint
dc.subjectGeneral & internal medicine
dc.titleEvaluation of diagnostic performance of bd max ebp assay in patients with diarrheal illness
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationaab7d5dd-72a4-4f3a-a677-1fdf3e13cadc
relation.isAuthorOfPublication.latestForDiscoveryaab7d5dd-72a4-4f3a-a677-1fdf3e13cadc

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Saglik_vd_2022.pdf
Size:
154.09 KB
Format:
Adobe Portable Document Format

Collections